Literature DB >> 27165101

Incorporation of VSV-G produces fusogenic plasma membrane vesicles capable of efficient transfer of bioactive macromolecules and mitochondria.

Hao-Peng Lin1, De-Jin Zheng1, Yun-Pan Li1, Na Wang1, Shao-Jun Chen1, Yu-Cai Fu2, Wen-Can Xu3, Chi-Ju Wei4.   

Abstract

The objective of this study was to determine if plasma membrane vesicles (PMVs) could be exploited for efficient transfer of macro-biomolecules and mitochondria. PMVs were derived from mechanical extrusion, and made fusogenic (fPMVs) by incorporating the glycoprotein G of vesicular stomatitis virus (VSV-G). Confocal microscopy examination revealed that cytoplasmic proteins and mitochondria were enclosed in PMVs as evidenced by tracing with cytoplasmically localized and mitochondria-targeted EGFP, respectively. However, no fluorescence signal was detected in PMVs from cells whose nucleus was labeled with an EGFP-tagged histone H2B. Consistently, qRT-PCR measurement showed that mRNA, miRNA and mitochondrial DNA decreased slightly; while nuclear DNA was not measureable. Further, Western blot analysis revealed that cytoplasmic and membrane-bound proteins fell inconspicuously while nuclear proteins were barely detecsle. In addition, fPMVs carrying cytoplamic DsRed proteins transduced about ~40 % of recipient cells. The transfer of protein was further confirmed by using the inducible Cre/loxP system. Mitochondria transfer was found in about 20 % recipient cells after incubation with fPMVs for 5 h. To verify the functionalities of transferred mitochondria, mitochodria-deficient HeLa cells (Rho0) were generated and cultivated with fPMVs. Cell enumeration demonstrated that adding fPMVs into culture media stimulated Rho0 cell growth by 100 % as compared to the control. Lastly, MitoTracker and JC-1 staining showed that transferred mitochondria maintained normal shape and membrane potential in Rho0 cells. This study established a time-saving and efficient approach to delivering proteins and mitochondria by using fPMVs, which would be helpful for finding a cure to mitochondria-associated diseases. Graphical abstract Schematic of the delivery of macro-biomolecules and organelles by fPMVs. VSV-G-expressing cells were extruded through a 3 μm polycarbonate membrane filter to generate fusogenic plasma membrane vesicles (fPMVs), which contain bioactive molecules and organelles but not the nucleus. fPMVs can be endocytosed by target cells, while the cargo is released due to low-pH induced membrane fusion. These nucleus-free fPMVs are efficient at delivery of cytoplasmic proteins and mitochondria, leading to recovery of mitochondrial biogenesis and proliferative ability in mitochondria-deficient cells.

Entities:  

Keywords:  Macro-biomolecules; Mitochondria; Plasma membrane vesicles; Rho0 cells; VSV-G

Mesh:

Substances:

Year:  2016        PMID: 27165101     DOI: 10.1007/s10544-016-0066-y

Source DB:  PubMed          Journal:  Biomed Microdevices        ISSN: 1387-2176            Impact factor:   2.838


  4 in total

1.  Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy.

Authors:  Li-Qun Xu; Mei-Jia Lin; Yun-Pan Li; Shuang Li; Shao-Jun Chen; Chi-Ju Wei
Journal:  J Vis Exp       Date:  2017-05-18       Impact factor: 1.355

Review 2.  Stem cell-derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopathy.

Authors:  Kaiming Liu; Zhijian Zhou; Mengxiong Pan; Lining Zhang
Journal:  CNS Neurosci Ther       Date:  2021-02-03       Impact factor: 5.243

3.  Impact of pyriproxyfen on virus behavior: implications for pesticide-induced virulence and mechanism of transmission.

Authors:  Paula A Faria Waziry; Aarti Raja; Chloe Salmon; Nathalia Aldana; Sruthi Damodar; Andre Rinaldi Fukushima; Bindu S Mayi
Journal:  Virol J       Date:  2020-07-06       Impact factor: 4.099

4.  Plasma membrane vesicles of human umbilical cord mesenchymal stem cells ameliorate acetaminophen-induced damage in HepG2 cells: a novel stem cell therapy.

Authors:  Mei-Jia Lin; Shuang Li; Lu-Jun Yang; Dan-Yan Ye; Li-Qun Xu; Xin Zhang; Ping-Nan Sun; Chi-Ju Wei
Journal:  Stem Cell Res Ther       Date:  2020-06-08       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.